Frontotemporal Degeneration: Clinical Trials

14 trials for Frontotemporal Degeneration, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 4 completed, 3 unknown. 3 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 2, Completed 1
Phase 11Unknown 1
Phase 21Recruiting 1

Follow Frontotemporal Degeneration: new trials by email Literature Review of Frontotemporal Degeneration trials Research Report on Frontotemporal Degeneration

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia
Vortioxetine - Fronto-temporal Dementia, Fronto-temporal Lobar Dementia
Phase 2RecruitingJohns Hopkins University502025-03-202026-03-09
Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
Transcranial Alternating Current Stimulation, Digital Cognitive Training - Cognitive Dysfunction, Alzheimer Disease
Not applicableRecruitingUniversidade Federal do Rio de Janeiro402024-12-022024-12-13
IL-2 Plus Abatacept in FTD
Abatacept plus Aldesleukin - Frontotemporal Degeneration
Phase 1UnknownThe Methodist Hospital Research Institute102024-05-062025-03-10
Advances in Telephone-based Cognitive Screening Procedures
Telephone-based neuropsychological assessment - ALS, Telephone-based neuropsychological assessment - AD, LBD, FTD and CVD, Telephone-based and in-person cognitive screening - NIs - Amyotrophic Lateral Sclerosis, Alzheimer's Disease
RecruitingIstituto Auxologico Italiano2802023-10-252024-03-29
The Swedish BioFINDER - Memory Clinic Study
Plasma Amyloid Probability Score 2 (APS 2) score, Plasma ptau217/nptau217, Plasma ptau217 - Mild Dementia, Mild Cognitive Impairment
RecruitingSkane University Hospital12002022-12-012026-04-06
Telehealth-enabled Integrated Palliative Care for People With Dementia
Telehealth Integrated Primary Care (TIPC) - Dementia of Alzheimer Type, Alzheimer Disease
Not applicableCompletedThomas Jefferson University502022-06-292025-02-12
In Vivo PET of Synaptic Density in Cognitive Disorders
[18F]-SynVesT-1 - Alzheimer Disease, Frontotemporal Degeneration
CompletedUniversitaire Ziekenhuizen KU Leuven1342022-04-112026-01-08
Clearance Mechanisms in Atypical Neurodegenerative Diseases
Neurodegenerative Diseases, Frontotemporal Degeneration
UnknownLudwig-Maximilians - University of Munich802022-04-012023-03-09
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Amyotrophic Lateral Sclerosis, Primary Lateral Sclerosis
RecruitingUniversity of Alberta1502021-09-122026-04-13
The Swedish BioFINDER - Primary Care Study
Plasma APS 2 score, Plasma p-tau217/np-tau217, Plasma p-tau217 - Mild Dementia, Mild Cognitive Impairment
RecruitingSkane University Hospital12002020-01-012026-04-06
Voices Of Individuals: Challenges and Experiences Of bvFTD
Telephone Interview - Frontotemporal Dementia, Frontotemporal Degeneration
CompletedUniversity of Pennsylvania262019-06-262026-01-12
The Swedish BioFINDER 2 Study
Flutemetamol F18 Injection, [18F]-RO6958948, Elecsys (Roche) Abeta42, Ttau and Ptau - Dementia, Alzheimer Disease
Not applicableRecruitingSkane University Hospital29502017-05-152026-04-06
Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
Frontotemporal Dementia, Frontotemporal Degeneration
UnknownUniversity of California, Los Angeles992010-01-012011-10-28
Cognitive Impairement In Frontotemporal Dementia
None-Observation Only - Frontotemporal Degeneration, Progressive Supranuclear Palsy
CompletedUniversity of Pennsylvania9972003-07-012020-11-12

Narrower conditions

Alzheimer Disease (8)  ·  Lewy Body Disease (7)  ·  Frontotemporal Dementia (5)  ·  Cognitive Dysfunction (4)  ·  Dementia, Vascular (4)  ·  Amyotrophic Lateral Sclerosis (3)  ·  Dementia (3)  ·  Pick Disease of the Brain (3)  ·  Disease (2)  ·  Multiple System Atrophy (2)  ·  Supranuclear Palsy, Progressive (2)  ·  Behavior (1)  ·  Cerebrovascular Disorders (1)  ·  Corticobasal Degeneration (1)  ·  Disease Progression (1)

Broader conditions

Nervous System Diseases (13)  ·  Central Nervous System Diseases (12)  ·  Neurodegenerative Diseases (12)  ·  Brain Diseases (11)  ·  Neurocognitive Disorders (10)  ·  Mental Disorders (9)  ·  Tauopathies (9)  ·  Basal Ganglia Diseases (8)  ·  Movement Disorders (8)  ·  Synucleinopathies (8)  ·  Dementia (7)  ·  Metabolic Diseases (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Parkinsonian Disorders (7)  ·  Proteostasis Deficiencies (7)

Interventions

Abatacept (1)  ·  Interviews as Topic (1)  ·  Magnetic Resonance Imaging (1)  ·  SynVesT-1 (1)  ·  Transcranial Direct Current Stimulation (1)  ·  Vortioxetine (1)  ·  aldesleukin (1)

Sponsors

Skane University Hospital (3)  ·  University of Pennsylvania (2)  ·  Istituto Auxologico Italiano (1)  ·  Johns Hopkins University (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  The Methodist Hospital Research Institute (1)  ·  Thomas Jefferson University (1)  ·  Universidade Federal do Rio de Janeiro (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University of Alberta (1)  ·  University of California, Los Angeles (1)

Countries

United States (6)  ·  Sweden (3)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Erik Stomrud, MD, PhD (2)  ·  Christopher Morrow, MD (1)  ·  Erik Stomrud, MD, Phd (1)  ·  Jill Owczarzak, PhD (1)  ·  Koen Van Laere, MD, PhD, DSc (1)  ·  Lori Erby, PhD, ScM (1)  ·  Mario F Mendez, MD, PhD (1)  ·  Robert Perneczky, Prof. Dr. (1)  ·  Rogerio Panizzutti, Professor (1)  ·  Sanjay Kalra, MD (1)

Results publications

PMID 34937781, PMID 38347458, PMID 41343582, PMID 41864233, PMID 42219995, PMID 42348024

NIH funding

K23AG088248 (1), R01AG034499 (1)